
Treatment updates
MUSC tests Moodivate app with cancer patients
The Post and Courier reports that MUSC is testing its Moodivate app in a clinical trial involving cancer patients, a group in which depression can affect up to 40 percent.
September 24, 2026 · Source: The Post and Courier
Read the update




